Earnings Release • Aug 27, 2015
Earnings Release
Open in ViewerOpens in native device viewer
| Informazione Regolamentata n. 0481-46-2015 |
Data/Ora Ricezione 27 Agosto 2015 14:45:17 |
MTA - Star | ||
|---|---|---|---|---|
| Societa' | : | El.En. | ||
| Identificativo Informazione Regolamentata |
: | 62524 | ||
| Nome utilizzatore | : | ELENN01 - Romagnoli | ||
| Tipologia | : | IRAG 07; AVVI 02; AVVI 16; IRAG 02 | ||
| Data/Ora Ricezione | : | 27 Agosto 2015 14:45:17 | ||
| Data/Ora Inizio Diffusione presunta |
: | 27 Agosto 2015 15:00:18 | ||
| Oggetto | : | El.En. Spa: the Bod releases the six months financial report as of June 30, 2015 |
||
| Testo del comunicato |
Vedi allegato.
IRAG02 AVVI02 AVVI16 IRAG07
Press release
2015 guidance improved Revenue up 33% EBIT doubled Vs 2014 ( net of one-time proceeds)
Main consolidated financial results as of June 30, 2015
Florence, August 27th , 2015 –The Board of Directors of El.En. SpA, leader on the laser market and listed on the STAR Segment of the Italian Stock Exchange, released today the six months consolidated financial report as of June 30, 2015.
In the first half of 2015 the Group registered brilliant results: consolidated Revenue was 106,9 million of euro, up 33% on the first six months of 2014 (80,4 million of euro) and EBIT reached 10,4 million of euro, close to 10% on Revenue and up 60% on the first half of 2014 ( up 107% considering 2014 net of the one-time proceeds). The results are sensibly improving the average reported by our major competitors.
The Group gained a competitive position of absolute excellence due to the uniqueness of its products offer, always including technological innovations. It also benefited from the foreign exchange Euro/US Dollar finally at a level which is not penalizing the European manufacturers.
We registered a revenue growth exceeding 30% on both our reference markets, laser systems for Medical and Aesthetic applications ("Medical") and laser systems for manufacturing applications ("Industrial"), also exceeding 35% growth in the Industrial market. The growth took place in all the geographical areas we cover, with a stronger thrust on the international and North American markets.
Gross Margin of the Group was 48,1 million of euro, up 26,3% on the 38,1 million of euro of the corresponding period of 2014. The Gross Margin percentage on revenue was lower by two points from 47,3% of the first semester 2014 to 45% in 2015, as an effect of the reduced amount of grants for research activities and also for the increasing weight of sales with lower marginality in the industrial sector on the Chinese market.
EBITDA was 12,5 million of euro, up 77,9% on the 7,0 million of euro as of June 30th, 2014. The cost for staff was 20,9 million of euro showing a 13% increase on the 18,5 million of euro of the first half of 2014, though registering a market productivity increase from 23% on revenue to 19,6% as of June 30th, 2015.
EBIT was equal to 10,4 million of euro, (with a 9,7% impact on revenue) showing a 60% improvement, very solid also considering that without the one-time proceed of 1,5 million registered in 2014 the increase would be roughly 5 million of euro, more than doubling 2014's income from operations.
Income before taxes was 11,7 million of euro, up 3,0% on the 11,3 million of euro as of June 30th, 2014. Again, excluding for the 2014 income the one-time proceeds for 6,0 million of euro stemming from the "Palomar" settlement and the sale of Cynosure shares, the actual improvement of the income before taxes was 6 million of euro meaning up 115%.
Net income for the Group of the first half of 2015 was 7,6 million of euro, in light decrease on the 8,4 million of euro of the same period in 2014. A very positive achievement, considering that in addition of the one-time 6 million proceeds in the income before taxes, 2104 had benefited also of a lower tax rate, 21% vs. 28% in 2015, due to the partial tax exemption known as "PEX" on the gain on the sale of Cynosure shares. Excluding the one-time proceeds from 2014, net income in the first half of 2015 increased by 4,5 million of euro, up 148%.
The Net financial position of the group as of June 30th, 2015 was positive for 24,8 million of euro, down on the 47,1 million as of December 31st, 2104. During the first months of the year 2015 9,5 million of liquidity have been allocated in temporary financial investments the for their own nature need to be booked within non-current assets, and aren't therefore included anymore within the net financial position. Moreover, the amount of dividends paid to shareholders in the period was 5,4 million of euro.
For what concerns the trend of the current year, the results of the first half of 2015 are aligned with the most optimistic of the released guidance, meaning annual consolidated revenue of 200 million of euro and EBIT of 20 million of euro.
Gabriele Clementi, President of El.En. S.p.A. said "We are very pleased and satisfied with the excellent results achieved in the first half of 2015: they are confirming our growth potential, with a profitability of operations back to the best levels reached by El.En. before the 2008 downturn. We count on exceeding 210 million of euro of annual revenue and 20 million of EBIT, given that the very recent turbulences on the markets will maintain their impact on foreign exchange rates and general confidence to a limited oscillation."
The manager in charge of preparing the corporate accounting records, Enrico Romagnoli, declares, pursuant to paragraph 2, article 154-bis of the Consolidated Finance Law, that the accounting disclosures provided in this document correspond to the accounting records, books and entries.
As required by Consob, the Half Yearly Report as of June 30th, 2015 will be available for the public at our premises in Calenzano, at Borsa Italiana SpA, on our website www.elengroup.com (section "Investor Relations / Relazioni e Bilanci") and on authorized storage website from August 27th , 2015.
El.En., an Italian company, is the parent of a high-.tech industrial group operating in the optoelectronics sector. Based on proprietary technology and multidisciplinary know-how, the El.En Group manufactures laser sources (gas, semiconductor, solid-state and liquid) and innovative laser systems for medical and industrial applications. The El.En. Group is the laser market leader in Italy and among the top operators in Europe. It designs, manufactures and sells worldwide:
- Medical laser equipment used in dermatology, cosmetics, physiotherapy, dentistry and gynecology;
- Industrial laser systems for applications ranging from cutting, marking and welding metals, wood, plastic and glass to decorating leather and textiles and restoring/conserving artwork;
- Laser systems for scientific research
EL.EN has been listed on the Star (MTA) of Borsa Italiana. Its market floatation is approximately 44% and its market capitalization amounts to Euro 190 million.
Cod. ISIN: IT0001481867 Code: ELN Listed on MTA Mkt capt.:190 mln/Euro Cod. Reuters: ELN.MI Cod. Bloomberg: ELN IM
For further information:
El.En. SpA Polytems HIR Polytems HIR Enrico ROMAGNOLI Veronica ADRIANI Bianca FERSINI MASTELLONI Investor Relations Manager Press Office Financial Communication Tel. +39-055-8826807 Tel. +39/06 6797849;+39/345 5988195 Tel.+39/066797849–0669923324 [email protected] [email protected] [email protected]
| Income Statement | 30/06/15 | Inc.% | 30/06/14 | Inc.% | Var.% |
|---|---|---|---|---|---|
| Revenues | 106.884 | 100,0% | 80.398 | 100,0% | 32,9% |
| Change in inventory of finished goods and WIP | 1.623 | 1,5% | 3.823 | 4,8% | -57,6% |
| Other revenues and income | 961 | 0,9% | 1.276 | 1,6% | -24,7% |
| Value of production | 109.469 | 102,4% | 85.497 | 106,3% | 28,0% |
| Purchase of raw materials | 59.250 | 55,4% | 41.779 | 52,0% | 41,8% |
| Change in inventory of raw material | (5.737) | -5,4% | (1.018) | -1,3% | 463,4% |
| Other direct services | 7.878 | 7,4% | 6.678 | 8,3% | 18,0% |
| Gross margin | 48.077 | 45,0% | 38.058 | 47,3% | 26,3% |
| Other operating services and charges | 14.643 | 13,7% | 12.519 | 15,6% | 17,0% |
| Added value | 33.434 | 31,3% | 25.540 | 31,8% | 30,9% |
| For staff costs | 20.905 | 19,6% | 18.495 | 23,0% | 13,0% |
| EBITDA | 12.529 | 11,7% | 7.044 | 8,8% | 77,9% |
| Depreciation, amortization and other accruals | 2.155 | 2,0% | 561 | 0,7% | 284,4% |
| EBIT | 10.374 | 9,7% | 6.484 | 8,1% | 60,0% |
| Net financial income (charges) | 1.221 | 1,1% | 425 | 0,5% | 187,1% |
| Share of profit of associated companies | 99 | 0,1% | (1) | 0,0% | |
| Other net income (expense) | 0 | 0,0% | 4.451 | 5,5% | |
| Income (loss) before taxes | 11.694 | 10,9% | 11.359 | 14,1% | 3,0% |
| Income taxes | 3.235 | 3,0% | 2.339 | 2,9% | 38,3% |
| Income (loss) for the financial period | 8.459 | 7,9% | 9.019 | 11,2% | -6,2% |
| Minority interest | 836 | 0,8% | 527 | 0,7% | 58,5% |
| Net income (loss) | 7.623 | 7,1% | 8.492 | 10,6% | -10,2% |
| 30/06/2015 | 31/12/2014 | Var. | |
|---|---|---|---|
| Statement of financial position | |||
| Intangible assets | 3.705 | 3.613 | 92 |
| Tangible assets | 29.506 | 26.927 | 2.579 |
| Equity investments | 37.893 | 25.549 | 12.344 |
| Deferred tax assets | 6.374 | 5.682 | 692 |
| Other non current assets | 9.526 | 3 | 9.523 |
| Total non current assets | 87.004 | 61.775 | 25.229 |
| Inventories | 58.438 | 50.481 | 7.958 |
| Accounts receivables | 59.337 | 47.947 | 11.390 |
| Tax receivables | 6.984 | 6.618 | 366 |
| Other receivables | 8.998 | 8.415 | 583 |
| Financial instruments | 1.995 | 1.995 | |
| Cash and cash equivalents | 44.659 | 73.804 | -29.145 |
| Total current assets | 180.411 | 187.264 | -6.853 |
| TOTAL ASSETS | 267.415 | 249.039 | 18.376 |
| Share capital | 2.509 | 2.509 | |
| Additional paid in capital | 38.594 | 38.594 | |
| Other reserves | 80.590 | 50.291 | 30.299 |
| Retained earnings / (deficit) | 28.158 | 35.043 | -6.885 |
| Net income / (loss) | 7.623 | 16.520 | -8.897 |
| Share Capital and Reserves attributable to the Shareholders' of the Parent | |||
| Company | 157.474 | 142.957 | 14.518 |
| Share Capital and Reserves attributable to non-controlling interests | 8.332 | 7.579 | 753 |
| Total equity | 165.807 | 150.536 | 15.271 |
| Severance indemnity | 3.509 | 3.700 | -191 |
| Deferred tax liabilities | 1.590 | 1.461 | 129 |
| Other accruals | 2.892 | 2.695 | 197 |
| Financial liabilities | 4.823 | 5.907 | -1.084 |
| Non current liabilities | 12.814 | 13.763 | -949 |
| Financial liabilities | 17.203 | 21.494 | -4.291 |
| Accounts payables | 40.395 | 35.267 | 5.128 |
| Income tax payables | 3.737 | 2.223 | 1.514 |
| Other payables | 27.459 | 25.756 | 1.703 |
| Current liabilities | 88.794 | 84.740 | 4.054 |
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | 267.415 | 249.039 | 18.376 |
| Financial statement (cash flow) | 30/06/2015 | 30/06/2014 |
|---|---|---|
| Cash flow generated by operating activity: | ||
| Profit (loss) for the financial period | 8.459 | 9.019 |
| Amortizations and depreciations | 1.515 | 1.240 |
| Gain on investment AFS | -4.467 | |
| Devaluations of equity investments | 34 | |
| Share of profit of associated companies | -99 | 1 |
| Change of employee severance indemnity | -191 | 132 |
| Change of provisions for risks and charges | 197 | -1.985 |
| Change of provisions for deferred income tax assets | -692 | -168 |
| Change of provisions for deferred income tax liabilities | 129 | -243 |
| Stocks | -7.958 | -4.314 |
| Receivables | -11.390 | 3.388 |
| Tax receivables | -366 | -2.304 |
| Other receivables | -1.166 | -3.184 |
| Payables | 5.128 | -3.871 |
| Income Tax payables | 1.514 | 183 |
| Other payables | 1.703 | 5.891 |
| -11.675 | -9.667 | |
| Cash flow generated by operating activity | -3.215 | -648 |
| Cash flow generated by investment activity: | ||
| (Increase) decrease in tangible assets | -4.006 | -1.445 |
| (Increase) decrease in intangible assets | -180 | -172 |
| (Increase) decrease in equity investments and non current assets | -10.052 | 23.183 |
| Increase (decrease) in financial receivables | 583 | 774 |
| (Increase) decrease investments which are not permanent | -1.995 | 250 |
| Cash flow generated by investment activity | -15.650 | 22.590 |
| Cash flow from financing activity: | ||
| Increase (decrease) in non current financial liabilities | ||
| Increase (decrease) in current financial liabilities | -1.084 | -1.582 |
| Dividends distributed | -4.291 | -1.945 |
| Cash flow from financing activity | -5.391 | -2.950 |
| -10.766 | -6.476 | |
| Change in cumulative conversion adjustment reserve and other no monetary changes |
486 | 284 |
| Increase (decrease) in cash and cash equivalents | -29.145 | 15.750 |
| Cash and cash equivalents at the beginning of the financial period | 73.804 | 42.868 |
| Cash and cash equivalents at the end of the financial period | ||
| 44.659 | 58.618 |
In accordance with the recommendation CESR/05-178b on alternative performance indicators, the Group uses, in addition to the financial information required by IFRS, some information derived from the latter, although not required by IFRS (non - GAAP measures). These are presented in order to allow a better assessment of the performance and the management of the group and should not be considered as alternatives to those required by IFRS.
The Group uses the following alternative performance indicators to evaluate the financial performance:
The Group uses as alternative performance indicators to evaluate their ability to cope with financial obligations:
The alternative performance measures are used by the Issuer to monitor and evaluate the performance of the group and are not defined as accounting measures either within Italian GAAP or the IAS / IFRS. Therefore, the criteria used by the Group may not be consistent with those adopted by other operators and / or groups and therefore may not be comparable.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.